CAPN3: A muscle-specific calpain with an important role in the pathogenesis of diseases (Review)

被引:27
作者
Chen, Lin [1 ,2 ]
Tang, Fajuan [1 ,2 ]
Gao, Hu [1 ,2 ]
Zhang, Xiaoyan [1 ,2 ]
Li, Xihong [1 ,2 ]
Xiao, Dongqiong [1 ,2 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Emergency Med, 20 Renmin South Rd,Sect 3, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu 610041, Sichuan, Peoples R China
基金
美国国家科学基金会;
关键词
CAPN3; muscle formation; muscle remodeling; limb-girdle muscular dystrophy type 2A; GIRDLE MUSCULAR-DYSTROPHY; KAPPA-B PATHWAY; SKELETAL-MUSCLE; PROTEOLYTIC ACTIVITY; DNA METHYLATION; PROTEIN COMPLEX; LGMD2A PATIENTS; MESSENGER-RNA; MOUSE MODEL; FACTOR C;
D O I
10.3892/ijmm.2021.5036
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Calpains are a family of Ca2+-dependent cysteine proteases that participate in various cellular processes. Calpain 3 (CAPN3) is a classical calpain with unique N-terminus and insertion sequence 1 and 2 domains that confer characteristics such as rapid autolysis, Ca2+-independent activation and Na+ activation of the protease. CAPN3 is the only muscle-specific calpain that has important roles in the promotion of calcium release from skeletal muscle fibers, calcium uptake of sarcoplasmic reticulum, muscle formation and muscle remodeling. Studies have indicated that recessive mutations in CAPN3 cause limb-girdle muscular dystrophy (MD) type 2A and other types of MD; eosinophilic myositis, melanoma and epilepsy are also closely related to CAPN3. In the present review, the characteristics of CAPN3, its biological functions and roles in the pathogenesis of a number of disorders are discussed.
引用
收藏
页数:13
相关论文
共 123 条
[1]   Identification of neural stem cells in the adult vertebrate brain [J].
Alvarez-Buylla, A ;
Seri, B ;
Doetsch, F .
BRAIN RESEARCH BULLETIN, 2002, 57 (06) :751-758
[2]   Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis [J].
Amici, David R. ;
Pinal-Fernandez, Iago ;
Mazala, Davi A. G. ;
Lloyd, Thomas E. ;
Corse, Andrea M. ;
Christopher-Stine, Lisa ;
Mammen, Andrew L. ;
Chin, Eva R. .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2017, 5 :24
[3]   Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies) [J].
Anderson, LVB ;
Harrison, RM ;
Pogue, R ;
Vafiadaki, E ;
Pollitt, C ;
Davison, K ;
Moss, JA ;
Keers, S ;
Pyle, A ;
Shaw, PJ ;
Mahjneh, I ;
Argov, Z ;
Greenberg, CR ;
Wrogemann, K ;
Bertorini, T ;
Goebel, HH ;
Beckmann, JS ;
Bashir, R ;
Bushby, KMD .
NEUROMUSCULAR DISORDERS, 2000, 10 (08) :553-559
[4]  
Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3
[5]  
1-R
[6]  
FT710
[7]   Pathophysiology of limb girdle muscular dystrophy type 2A:: hypothesis and new insights into the IκBα/NF-κB survival pathway in skeletal muscle [J].
Baghdiguian, S ;
Richard, I ;
Martin, M ;
Coopman, P ;
Beckmann, JS ;
Mangeat, P ;
Lefranc, G .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (5-6) :254-261
[8]   Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A [J].
Baghdiguian, S ;
Martin, M ;
Richard, I ;
Pons, F ;
Astier, C ;
Bourg, N ;
Hay, RT ;
Chemaly, R ;
Halaby, G ;
Loiselet, J ;
Anderson, LVB ;
de Munain, AL ;
Fardeau, M ;
Mangeat, P ;
Beckmann, JS ;
Lefranc, G .
NATURE MEDICINE, 1999, 5 (05) :503-511
[9]   Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A [J].
Bartoli, M ;
Roudaut, C ;
Martin, S ;
Fougerousse, F ;
Suel, L ;
Poupiot, J ;
Gicquel, E ;
Noulet, F ;
Danos, O ;
Richard, I .
MOLECULAR THERAPY, 2006, 13 (02) :250-259
[10]   Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance [J].
Beckmann, Jacques S. ;
Spencer, Melissa .
NEUROMUSCULAR DISORDERS, 2008, 18 (12) :913-921